INOTEK PHARMACEUTICALS CORP's ticker is ITEK and the CUSIP is 45780V102. A total of 58 filers reported holding INOTEK PHARMACEUTICALS CORP in Q1 2016. The put-call ratio across all filers is - and the average weighting 1.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $881,000 | +48.1% | 337,765 | +1.0% | 0.00% | – |
| Q3 2017 | $595,000 | -7.2% | 334,445 | -0.9% | 0.00% | – |
| Q2 2017 | $641,000 | -68.8% | 337,563 | -67.2% | 0.00% | – |
| Q1 2017 | $2,057,000 | +664.7% | 1,028,759 | +2233.0% | 0.00% | – |
| Q4 2016 | $269,000 | -65.2% | 44,096 | -45.9% | 0.00% | -100.0% |
| Q3 2016 | $773,000 | +27.6% | 81,496 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $606,000 | +1.3% | 81,496 | +0.8% | 0.00% | 0.0% |
| Q1 2016 | $598,000 | -34.7% | 80,811 | 0.0% | 0.00% | 0.0% |
| Q4 2015 | $916,000 | +3.2% | 80,811 | -14.5% | 0.00% | 0.0% |
| Q3 2015 | $888,000 | – | 94,511 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Devon Park Associates, LLC | 3,243,709 | $36,751,000 | 100.00% |
| RHO CAPITAL PARTNERS INC | 2,627,790 | $29,773,000 | 10.24% |
| Private Capital Advisors, Inc. | 341,000 | $3,864,000 | 1.67% |
| NEXTHERA CAPITAL LP | 42,000 | $476,000 | 0.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 360,000 | $4,079,000 | 0.60% |
| SENZAR ASSET MANAGEMENT, LLC | 309,600 | $3,507,768,000 | 0.39% |
| Graticule Asia Macro Advisors LLC | 148,000 | $1,676,000 | 0.27% |
| FT Options LLC | 26,421 | $299,000 | 0.22% |
| EAM Investors, LLC | 128,911 | $1,461,000 | 0.19% |
| Tekla Capital Management LLC | 425,000 | $4,815,000 | 0.18% |